These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 19104433

  • 21. C4d-positive renal transplants: single-center clinical outcomes.
    Ciszek M, Ptasińska AP, Durlik M, Paczek L.
    Clin Transpl; 2006; ():405-12. PubMed ID: 18365397
    [Abstract] [Full Text] [Related]

  • 22. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK.
    Clin Transplant; 2007 Jun; 21(2):159-65. PubMed ID: 17425739
    [Abstract] [Full Text] [Related]

  • 25. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding.
    Al Aly Z, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B.
    Transpl Int; 2005 Jul; 18(7):800-5. PubMed ID: 15948858
    [Abstract] [Full Text] [Related]

  • 26. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K.
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M, Sole M, Arostegui JL, Mila J, Martorell J, Oppenheimer F.
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [Abstract] [Full Text] [Related]

  • 28. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.
    Worthington JE, McEwen A, McWilliam LJ, Picton ML, Martin S.
    Transplantation; 2007 Feb 27; 83(4):398-403. PubMed ID: 17318071
    [Abstract] [Full Text] [Related]

  • 29. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.
    Transplant Proc; 2007 Nov 27; 39(9):2718-20. PubMed ID: 18021967
    [Abstract] [Full Text] [Related]

  • 30. The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients.
    Cheunsuchon B, Vongwiwatana A, Premasathian N, Shayakul C, Parichatikanond P.
    Transplant Proc; 2009 Nov 27; 41(9):3697-700. PubMed ID: 19917370
    [Abstract] [Full Text] [Related]

  • 31. Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system.
    Al-Aly Z, Reddivari V, Moiz A, Balasubramanian G, Cortese CM, Salinas-Madrigal L, Bastani B.
    Transpl Int; 2008 Mar 27; 21(3):268-75. PubMed ID: 18069927
    [Abstract] [Full Text] [Related]

  • 32. Late acute kidney transplant rejection: clinicopathological correlates and response to corticosteroid therapy.
    Nair R, Agrawal N, Lebaeau M, Tuteja S, Chandran PK, Suneja M.
    Transplant Proc; 2009 Dec 27; 41(10):4150-3. PubMed ID: 20005357
    [Abstract] [Full Text] [Related]

  • 33. C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients: single-center incidence and outcome.
    Valente M, Furian L, Marchini F, Marino S, Cardillo M, Rigotti P, Aiello FB.
    Transplant Proc; 2010 Dec 27; 42(6):2214-7. PubMed ID: 20692447
    [Abstract] [Full Text] [Related]

  • 34. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B, Halloran PF.
    Curr Opin Organ Transplant; 2010 Feb 27; 15(1):42-8. PubMed ID: 20009933
    [Abstract] [Full Text] [Related]

  • 35. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES.
    Transplantation; 2010 Feb 15; 89(3):277-84. PubMed ID: 20145517
    [Abstract] [Full Text] [Related]

  • 36. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.
    Holt DB, Liapis H, Mohanakumar T, Phelan DR, Gandi SK, Huddleston CB, Canter CE.
    J Heart Lung Transplant; 2008 Oct 15; 27(10):1073-8. PubMed ID: 18926396
    [Abstract] [Full Text] [Related]

  • 37. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K, Yamaguchi Y, Shimizu T, Horita S, Furusawa M, Tanabe K, Fuchinoue S, Toma H.
    Clin Transplant; 2004 Oct 15; 18 Suppl 11():7-12. PubMed ID: 15191366
    [Abstract] [Full Text] [Related]

  • 38. Focal peritubular capillary C4d deposition in acute rejection.
    Magil AB, Tinckam KJ.
    Nephrol Dial Transplant; 2006 May 15; 21(5):1382-8. PubMed ID: 16396975
    [Abstract] [Full Text] [Related]

  • 39. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug 15; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 40. Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation.
    Rangel EB, Malheiros DM, de Castro MC, Antunes I, Torres MA, Crescentini F, Genzini T, Perosa M.
    Transpl Int; 2010 Jun 15; 23(6):602-10. PubMed ID: 20028489
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.